Blood Coagulation Testing Market Research Report - Global Forecast till 2027

Blood Coagulation Testing Market Information: By Product (Clinical Laboratory, Automated), Application (Bleeding Disorders, Von Willebrand Disease), Test Type (Testing Kits), and End Users (Academic Institutions, Hospitals) - Global Forecast till 2027

ID: MRFR/LS/0464-HCR | February 2021 | Region: Global | 115 pages

Please note that the assessment period of report has been updated from 2017–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Blood coagulation or clotting is the process by which blood changes from liquid to gel, thus, forming clots. These clots result in cessation of bleeding. However, the process of coagulation is hindered in the people suffering from liver disease, thrombophilia, and hemophilia. Various blood coagulation testing procedures are used for diagnosing these diseases, which provide the status of the hemostatic functioning of the patient. Haemostatic involves a coordinated series of interactions between platelets and numerous blood clotting proteins. With increasing prevalence of hemostatic diseases, the demand for blood coagulation testing has increased. To analyses the treatment efficiency against hemostatic diseases, the blood clotting testing is required.

The liver plays an important role in the normal functioning of hemostasis, which helps in preventing bleeding and undue activation of coagulation. According to the Centers for Disease Control and Prevention (CDC), in 2015, around 3.9 million adults were diagnosed with liver disease, which is about 1.6% of adult population of the U.S.

According to a study conducted by the Global Burden of Disease Liver Cancer Collaboration, in 2015, around 854,000 new incidents of liver cancer were found and 810,000 deaths occurred owing to liver cancer globally. Furthermore, it is the sixth most common-incident cancer globally and the fourth most common cause of cancer death.

Moreover, advancing technology in blood coagulation testing is adding fuel to the growth of the market. Furthermore, increasing prevalence of liver disease, thrombophilia, and hemophilia also drives the market growth. However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.

The global blood coagulation testing market is expected to grow at a CAGR of 6.5 % during the forecast period 2017-2023.


 


Intended Audience



  • Medical Diagnostic Kit Manufacturers

  • Pharmaceutical Industries

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Figure: Global Blood Coagulation Testing Market, By Region Market Share, 2016 (%) Global Blood Coagulation Testing Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The global blood coagulation market is segmented on the basis of product, application, test type, and end user.


On the basis of the product, the market is segmented into clinical laboratory, automated testing, and semi-automated testing.


On the basis of application, the market is segmented into congenital bleeding disorders, acquired bleeding disorders, Von Willebrand disease, and hemophilia.


On the basis of test type, the market is segmented into various testing kits and others. Furthermore, testing kits are segmented into prothrombin time (PT), activated clotting time, D dimer, and fibrinogen (FIB).


On the basis of the end user, the market is segmented into academic institutions, hospitals, and diagnostic laboratories.


Regional Analysis


The Americas dominate the global blood coagulation testing market owing to increasing patient with liver disease, von Willebrand disease (vWF), and hemophilia. Furthermore, well-developed technology, high health care spending, increasing government support for research & development, and the concentration of major companies have fuelled the growth of the market in this region.


Europe holds the second position in the global blood coagulation testing market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecast period. For instance, countries like Germany and France are increasing investment in the healthcare domain. According to a study conducted by Global Burden of Disease Liver Cancer Collaboration, in 2017, Western Europe ranked third in the liver cancer cases and fourth in liver cancer death.


The Asia Pacific is the fastest growing blood coagulation testing market owing to the presence of rapidly developing healthcare technology, a huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead to the use of advanced equipment, which, in turn, is likely to increase the growth of the blood coagulation testing Market in the region.


On the other hand, in the Middle East and Africa, blood disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.


Key Players


Some of the major players for the global blood coagulation market are F. Hoffmann-La Roche Ltd. (Europe), Alere Inc. (U.S.), Siemens Healthcare Private Limited (Europe), Accriva Diagnostics (U.S.A.), CoaguSense, Inc. (U.S.), HomoSonics LLC. (U.S.), iLine Microsystems. (Europe), Instrumentation Laboratory (U.S.), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.), Bio/Data Corporation (U.S.) 


Research Methodology


blood coagulation testing market-


Sources: Annual reports, Press release, White paper, and Company presentation



Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Blood Coagulation Testing Market, by Product

6.1 Introduction

6.2 Clinical Laboratory

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Automated

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Semi-Automated Testing

6.4.1 Market Estimates & Forecast, 2020-2027

7. Global Blood Coagulation Testing Market, by Application

7.1 Introduction

7.2 Bleeding Disorders

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Acquired Bleeding Disorders

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Von Willebrand Disease

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Hemophilia

7.5.1 Market Estimates & Forecast, 2020-2027

8. Global Blood Coagulation Testing Market, by Test Type

8.1 Introduction

8.2 Testing Kits

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Others

8.3.1 Market Estimates & Forecast, 2020-2027

9. Global Blood Coagulation Testing Market, by End User

9.1 Introduction

9.2 Academic Institutions

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Hospitals

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Diagnostic Laboratories

9.4.1 Market Estimates & Forecast, 2020-2027

10. Global Blood Coagulation Testing Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K.

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 F. Hoffmann-La Roche Ltd

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Alere Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Siemens Healthcare

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Accriva Diagnostics

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 CoaguSense, Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 HomoSonics LLC.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 SenGenix Inc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Blood coagulation testing Industry Synopsis, 2020-2027

Table 2 Global Blood coagulation testing Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Blood coagulation testing Market by Region, 2020-2027, (USD Million)

Table 4 Global Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 5 Global Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 6 Global Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 7 Global Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 8 North America Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 9 North America Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 10 North America Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 11 North America Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 12 US Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 13 US Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 14 US Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 15 US Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 17 Canada Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 18 Canada Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 19 Canada Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 20 South America Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 21 South America Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 22 South America Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 23 South America Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 25 Europe Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 26 Europe Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 27 Europe Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 29 Western Europe Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 30 Western Europe Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 31 Western Europe Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 33 Eastern Europe Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 34 Eastern Europe Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 35 Eastern Europe Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 37 Asia Pacific Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 38 Asia Pacific Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 39 Asia Pacific Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Blood coagulation testing Market by Products, 2020-2027, (USD Million)

Table 41 Middle East & Africa Blood coagulation testing Market by Application, 2020-2027, (USD Million)

Table 42 Middle East & Africa Blood coagulation testing Market by Test Type, 2020-2027, (USD Million)

Table 43 Middle East & Africa Blood coagulation testing Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Blood coagulation testing Market

Figure 3 Segmentation Market Dynamics for Blood coagulation testing Market

Figure 4 Global Blood coagulation testing Market Share, by Product 2020

Figure 5 Global Blood coagulation testing Market Share, by Application 2020

Figure 6 Global Blood coagulation testing Market Share, by Test Type 2020

Figure 7 Global Blood coagulation testing Market Share, by End Users, 2020

Figure 8 Global Blood coagulation testing Market Share, by Region, 2020

Figure 9 Americas Blood coagulation testing Market Share, by Country, 2020

Figure 10 Europe Blood coagulation testing Market Share, by Country, 2020

Figure 11 Asia Pacific Blood coagulation testing Market Share, by Country, 2020

Figure 12 Middle East & Africa Blood coagulation testing Market Share, by Country, 2020

Figure 13 Global Blood coagulation testing Market: Company Share Analysis, 2020 (%)

Figure 14 F. Hoffmann-La Roche Ltd: Key Financials

Figure 15 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 16 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 17 Alere Inc.: Key Financials

Figure 18 Alere Inc.: Segmental Revenue

Figure 19 Alere Inc.: Geographical Revenue

Figure 20 Siemens Healthcare: Key Financials

Figure 21 Siemens Healthcare: Segmental Revenue

Figure 22 Siemens Healthcare: Geographical Revenue

Figure 23 Accriva Diagnostics: Key Financials

Figure 24 Accriva Diagnostics: Segmental Revenue

Figure 25 Accriva Diagnostics: Geographical Revenue

Figure 26 CoaguSense, Inc.: Key Financials

Figure 27 CoaguSense, Inc.: Segmental Revenue

Figure 28 CoaguSense, Inc.: Geographical Revenue

Figure 29 HomoSonics LLC: Key Financials

Figure 30 HomoSonics LLC: Segmental Revenue

Figure 31 HomoSonics LLC: Geographical Revenue

Figure 32 SenGenix Inc.: Key Financials

Figure 33 SenGenix Inc.: Segmental Revenue

Figure 34 SenGenix Inc.: Geographical Revenue